HORIBA Medical is informing all ABX PENTRA MultiCal, N Control, and P Control customers running the
Creatinine Rate Blank Method assay on the ABX PENTRA 400 and PC200 that the Target Values for Creatinine Rate
Blank Method have been updated. This issue is only applicable to Creatinine Rate Blank Method values reported on the
ABX PENTRA 400 and PC200 Chemistry Analyzers only. No other analyzers
Source facts
Action
HORIBA Medical initiated this recall by sending customers recall communication via FedEx week of January 20, 2014. The recall communication was a Field Safety Notice letter and Acknowledgement Form. The letter, dated 01/20/2014, titled "URGENT SAFETY NOTICE", informed customers of the recall by providing product description and codes, issue, impact, actiona/resolution, and contact information. The letter contained the following attachments: Field Safety Notice Acknowledgement Form and Updated Annexes with re-assigned values.
Initiated
2014-01-20
Root cause
Under Investigation by firm
Terminated
2014-12-05
Distribution
United States nationwide distribution.
Recall number
Z-1146-2014
Recall status
Terminated
CDRH record ID
125274
FDA classified
2014-03-05
Recall event number
67332
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.